Published
2024-10-10
Section
Articles
How to Cite
肺弓形虫病的相关研究进展
赖 安毓
右江民族医学院
林 剑勇
右江民族医学院附属医院
DOI: https://doi.org/10.59429/xjjz.v6i3.7283
Keywords: 刚地弓形虫;肺部;肺弓形虫病;诊断
Abstract
肺弓形虫病是由刚地弓形虫感染所致的一种机会性疾病。弓形虫感染可导致全身多处器官损害,肺部是除 脑部以外最常见被累及的器官。肺弓形虫病临床表现无明显特征,诊断较困难,患者死亡率高。论文根据肺弓形虫 病的流行病学热点、感染方式、易感人群、临床表现、免疫病理机制及诊断治疗做一综述。
References
[1] KALOGEROPOULOS D, SAKKAS H, MOHAMMED B, et al. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches[J]. Int Ophthalmol,2022,42(1):295-321.
[2] S A E. Toxoplasmosis: stages of the protozoan life cycle and risk assessment in humans and animals for an enhanced awareness and an improved socio-economic status[J]. Saudi J Biol Sci, 2021,28(1):962-969.
[3] AJIOKA J W, MORRISSETTE N S. A century of Toxoplasma research[J]. Int J Parasitol,2009,39(8):859-860.
[4] LOPES C, BRANDAO R, LOPES A F, et al. Prevalence of Antibodies to Toxoplasma gondii in Different Wild Bird Species Admitted to Rehabilitation Centres in Portugal[J]. Pathogens,2021,10(9):1009-1144.
[5] AGUIRRE A A, LONGCORE T, BARBIERI M, et al. The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies[J]. Ecohealth,2019,16(2):378-390.
[6] A S S O N I L , N A K A S H I M A F, d e S O U S A V P, e t a l . Seroepidemiology of Toxoplasma gondii infection in blood donors in a population from the northwestern region of Sao Paulo state, Brazil[J]. Trans R Soc Trop Med Hyg,2024,118(2):102-109.
[7] M I L N E G C , W E B S T E R J P, WA L K E R M . I s t h e incidence of congenital toxoplasmosis declining?[J]. Trends Parasitol,2023,39(1):26-37.
[8] VELASCO-VELASQUEZ S, OROZCO A S, RAMIREZ M, et al. Impact of education on knowledge, attitudes, and practices for gestational toxoplasmosis[J]. J Infect Public Health, 2024,17(9):102516.
[9] VILELA V, FEITOSA T F. Recent Advances in Toxoplasma gondii Infection and Toxoplasmosis[J]. Trop Med Infect Dis, 2024,9(7):160-161.
[10] EL S N, EISSA M M. Shedding light on a mysterious link between Toxoplasma gondii and cancer: A review[J]. Exp Parasitol, 2023(250):108544.
[11] 赵紫琪,吕芳丽.免疫功能健全者获得性弓形虫病的研究进展[J].中国寄生虫学与寄生虫病杂志,2022,40(2):228-235.
[12] TILAHUN M, GEBRETSADIK D, SEID A, et al. Bacteriology of community-acquired pneumonia, antimicrobial susceptibility pattern and associated risk factors among HIV patients, Northeast Ethiopia: cross-sectional study[J]. SAGE Open Med, 2023(11):382970911.
[13] ZHAI W H, ZHANG L N, WANG J L, et al. Toxoplasma gondii infection after allogeneic hematopoietic stem cell transplantation in patients with hematological diseases: 2 cases report and literature reviews[J]. Zhonghua Xue Ye Xue Za Zhi,2023,44(10):861-863.
[14] HIRATE T, KITAZAWA H, SAKAGUCHI H, et al. Cerebral toxoplasmosis developed after unrelated bone marrow transplantation for acute myeloid leukemia[J]. Rinsho Ketsueki, 2023,64(10):1275-1279. [15] KAMEL N A, ABDALLA M S, AL A A, et al. Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation[J]. Infect Drug Resist,2024(17):2249-2260.
[16] CHUN-YUN L. Investigation on Toxoplasma gondii infections among patients with malignant tumors of the digestive tract in Hainan Province[J]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi,2019,31(4):427-430.
[17] PANGRACIO E, de MACEDO V, ALVES P K. Pulmonary and Renal Toxoplasmosis in an Immunocompetent Adult Patient[J]. J Med Cases,2023,14(2):50-53.
[18] LAYTON J, THEIOPOULOU D C, RUTENBERG D, et al. Clinical Spectrum, Radiological Findings, and Outcomes of Severe Toxoplasmosis in Immunocompetent Hosts: A Systematic Review[J]. Pathogens,2023,12(4):543-600.
[19] BEDER D, ESENKAYA T F. General Features and Laboratory Diagnosis of Toxoplasma gondii Infection[J]. Turkiye Parazitol Derg,2020,44(2):94-101.
[20] JAFARI M M, AZIMZADEH T Z, DAYER M S, et al. Immune system roles in pathogenesis, prognosis, control, and treatment of Toxoplasma gondii infection[J]. Int Immunopharmacol,2023,124(Pt A):110872.
[21] SANA M, RASHID M, RASHID I, et al. Immune response against toxoplasmosis-some recent updates RH: Toxoplasma gondii immune response[J]. Int J Immunopathol Pharmacol, 2022(36):1190298532.
[22] YUCESAN B. Molecular Models of Toxoplasma gondii in Humans and Animals[J]. Turkiye Parazitol Derg,2024,48(2):128-132.
[23] MARQUES-SANTOS F, FARIA R X, AMENDOEIRA M. The Search for Drugs Derived from Natural Products for Toxoplasma gondii Infection Treatment in the Last 20 Years - A Systematic Review[J]. Curr Top Med Chem,2024.
[24] 邱燕华,董朕,张吉丽,等.弓形虫病的治疗研究进展[J].中国动物传染病学报,2023,31(4):213-222.
[25] 孙晓敬,张磊,田甜,等.弓形虫病治疗:从传统药物到纳米药物[J].畜牧兽医学报,2023,54(5):1834-1844.
[26] 常江艳,李朝,非绍江,等.纳米技术在寄生虫学中的应用[J].中国畜牧兽医,2017,44(11):3294-3299.
[27] 李勃,庄冬生.纳米材料在抗菌药物载体方面的研究进展[J].天津医科大学学报,2022,28(1):105-107